HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

OCT1 Deficiency Affects Hepatocellular Concentrations and Pharmacokinetics of Cycloguanil, the Active Metabolite of the Antimalarial Drug Proguanil.

Abstract
Cycloguanil, the active metabolite of proguanil, acts on malaria schizonts in erythrocytes and hepatocytes. We analyzed the impact of the organic cation transporter OCT1 on hepatocellular uptake and pharmacokinetics of proguanil and cycloguanil. OCT1 transported both proguanil and cycloguanil. Common variants OCT1*3 and OCT1*4 caused a substantial decrease and OCT1*5 and OCT1*6 complete abolishment of proguanil uptake. In 39 healthy subjects, low-activity variants OCT1*3 and OCT1*4 had only minor effects on proguanil pharmacokinetics. However, both, cycloguanil area under the time-concentration curve and the cycloguanil-to-proguanil ratio were significantly dependent on number of these low-functional alleles (P = 0.02 for both). Together, CYP2C19, CYP3A5, OCT1 polymorphisms, and sex accounted for 61% of the variation in the cycloguanil-to-proguanil ratio. Most importantly, in vitro OCT1 inhibition caused a fivefold decrease of intracellular cycloguanil concentrations in primary human hepatocytes. In conclusion, OCT1-mediated uptake is a limiting step in bioactivation of proguanil, and OCT1 polymorphisms may affect proguanil efficacy against hepatic malaria schizonts.
AuthorsJohannes Matthaei, Tina Seitz, Ole Jensen, Annabelle Tann, Thomas Prukop, Sina Tadjerpisheh, Jürgen Brockmöller, Mladen V Tzvetkov
JournalClinical pharmacology and therapeutics (Clin Pharmacol Ther) Vol. 105 Issue 1 Pg. 190-200 (01 2019) ISSN: 1532-6535 [Electronic] United States
PMID29882324 (Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2018 American Society for Clinical Pharmacology and Therapeutics.
Chemical References
  • Antimalarials
  • Octamer Transcription Factor-1
  • POU2F1 protein, human
  • Triazines
  • cycloguanil
  • Proguanil
Topics
  • Adolescent
  • Adult
  • Antimalarials (metabolism, pharmacokinetics)
  • Dose-Response Relationship, Drug
  • Female
  • HEK293 Cells
  • Hepatocytes (drug effects, metabolism)
  • Humans
  • Male
  • Middle Aged
  • Octamer Transcription Factor-1 (deficiency)
  • Proguanil (metabolism, pharmacokinetics)
  • Triazines (metabolism, pharmacokinetics)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: